Reversal of stress-induced anhedonia by the atypical antidepressants, fluoxetine and maprotiline

Psychopharmacology

Volumn 109, Issue 4, 1992, Pages 433-438

  Muscat, Richard ^a   Papp, Mariusz ^a   Willner, Paul ^a  

^a LONDON METROPOLITAN UNIVERSITY   (United Kingdom)

Author keywords

Chlordiazepoxide; Fluoxetine; Maprotiline; Place preference conditioning; Rats; Reward; Stress; Sucrose drinking

Indexed keywords

ANTIDEPRESSANT AGENT; CHLORDIAZEPOXIDE; FLUOXETINE; MAPROTILINE; RACLOPRIDE; SUCROSE;

ANHEDONIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONDITIONING; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DRUG ANTAGONISM; DRUG THERAPY; DYSPHORIA; FOOD INTAKE; MALE; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; RAT; REWARD; STRESS;

ANIMAL; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CHLORDIAZEPOXIDE; CONDITIONING, OPERANT; DOPAMINE; EATING; FEEDING BEHAVIOR; FLUOXETINE; FOOD; MALE; MAPROTILINE; RATS; REWARD; STRESS, PSYCHOLOGICAL; SUCROSE; SUPPORT, NON-U.S. GOV'T;

EID: 0026467163     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/BF02247719     Document Type: Article

References (38)

1. Depression: the predisposing influence of stress
2. Prolonged treatment with the specific 5-HT uptake inhibitor citalopram: effect on dopaminergic and serotonergic functions
3. Therapeutic effects of serotonin uptake inhibitors in depression
4. Fluoxetine in depressed patients: a comparison with imipramine
5. Conditioned place preference as a measure of drug reward
6. Potential neuroleptic agents 4: chemistry, behavioral pharmacology, and inhibition of (3H)-spiperone binding of 3,5-disubstituted N-((1-ethyl-2-pyrrolidinyl)methyl)-6-methoxy-salicylates
7. Assessing anhedonia in psychiatric patients: the pleasure scale
8. Comparison of two modes of stress measurement: Daily hassles and uplifts versus major life events
9. Endogenomorphic depression: a conceptual and terminological revision
10. Repeated administration of antidepressant drugs enhanced agonist affinity for mesolimbic D-2 receptors
11. Chronic treatment with antidepressants decreases the number of [3H]SCH 23390 binding sites in the rat striatum and limbic system
12. Life events and depressive disorders reviewed. 2. Events as precipitating factors
13. Maprotiline—its position as an antidepressant in the light of recent neuropharmacological and neurobiochemical findings
14. Repeated treatment with antidepressant drugs and functional changes of catecholajminergic receptors at the behavioural level
15. Repeated treatment with imipramine or amitriptyline increases the locomotor response of rats to (+)-amphetamine given into the nucleus accumbens
16. The influence of oxaprotaline enantiomers given repeatedly on the behavioural effects of d-amphetamine and dopamine injected into the nucleus accumbens
17. Repeated treatment with antidepressant drugs potentiates the locomotor response to (+)-amphetamine
18. Repeated treatment with antidepressant drugs increases the behavioural response to apomorphine
19. Desipramine given repeatedly enhances behavioural effects of dopamine and d-amphetamine injected into the nucleus accumbens
20. Cholinergic-dopaminergic interactions and the mechanisms of action of antidepressants
21. Maprotiline, nomifensine, mianserin, zimelidine: a review of antidepressant efficacy in in-patients
22. Antidepressant treatment prevents chronic unpredictable mild stress-induced anhedonia as assessed by ventral tegmental self-stimulation behavior in rats
23. Changes in dopamine autoreceptor sensitivity in an animal model of depression
24. Dopaminergic mechanism of imipramine action in an animal model of depression
25. The symptoms of major depression
26. An animal model of anhedonia. Attenuation of sucrose consumption and place preference conditioning by chronic unpredictable mild stress
27. The effects of antidepressants and electroconvulsive shocks on the function of the mesolimbic dopamine system: a behavioural study
28. Reversal of antidepressant action by dopamine antagonists in an animal model of depression
29. Behavioural changes during withdrawal from the tricyclic antidepressant desmethylimipramine (DMI). I. Interactions with amphetamine
30. Reduction of sucrose preference by chronic mild stress and its restoration by a tricyclic antidepressant
31. Animal models of anhedonia
32. Stressor-provoked alterations of intracranial self-stimulation in the mesocortiolimbic dopamine system: an animal model of depression